Concepedia

K. J. Roozendaal

KJ

32

Publications

2.3K

Citations

22

H-Index

1975

Active since

Affiliations

OLVG(Current)

European Organisation for Research and Treatment of Cancer

The Netherlands Cancer Institute

Radboud University Nijmegen

University of Groningen

K. J. Roozendaal is an author at OLVG specializing in medicine, oncology, and pharmacology.

Top concepts

Publications per year

1975–2005

32

Publications

32

Aprotinin protects platelets against the initial effect of cardiopulmonary bypass

Willem van Oeveren, Marcel P. Harder, K. J. Roozendaal et al. · Journal of Thoracic and Cardiovascular Surgery · 1990 · 374 citations

, , +9

Cell-Derived Microparticles Generated in Patients During Cardiopulmonary Bypass Are Highly Procoagulant

Rienk Nieuwland, R.J. Berckmans, Reni C. Rotteveel-Eijkman et al. · Circulation · 1997 · 344 citations

Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass

Niels Jansen, Willem van Oeveren, L. van den Broek et al. · Journal of Thoracic and Cardiovascular Surgery · 1991 · 207 citations

, , +9

Maintenance chemotherapy in small-cell lung cancer: long-term results of a randomized trial. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.

Giuseppe Giaccone, Otilia Dalesio, Gordon McVie et al. · Journal of Clinical Oncology · 1993 · 148 citations

Standard Chemotherapy With or Without High-Dose Chemotherapy for Aggressive Non-Hodgkin's Lymphoma: Randomized Phase III EORTC Study

Hanneke C. Kluin‐Nelemans, Vittorina Zagonel, A. Anastasopoulou et al. · JNCI Journal of the National Cancer Institute · 2001 · 146 citations · Full text

Rows per page

1–5 of 32